Progestrone and Doppler Indices
- Conditions
- Preterm Labor
- Interventions
- Diagnostic Test: A complete Doppler flow assessment of the maternal and fetal circulation
- Registration Number
- NCT03292939
- Lead Sponsor
- Kasr El Aini Hospital
- Brief Summary
The aim of our study is to assess the effect of vaginal progestrone on fetal and maternal doppler indices
- Detailed Description
A complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of 400mg of vaginal progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine,equipped with a 3.5- MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 80
- Gestational age: 18-33 weeks
- Willing and able to give informed consent
- History of preterm labor (<34 weeks)
- At risk for preterm labor ( increased amniotic fluid volume)
- Short cervical length (<25mm) as incidental finding
- Presenting with actual cervical changes ( dilatation and\or effacement) in current pregnancy
- PPROM
- Contraindication to progesterone use
- Diabetic patients, have glucose intolerance
- Multiple pregnancies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description vaginal progestrone group A complete Doppler flow assessment of the maternal and fetal circulation cohort of patients who received 400mg vaginal progestrone .
- Primary Outcome Measures
Name Time Method change of ultrasound doppler indices. before and 48 hours after progestrone admistration A complete Doppler flow assessment of the maternaland fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasoundmachine,equippedwitha3.5-MHzcurvilinearabdominaltransducer with color imaging capabilities, was used in all cases.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kasr El Ainiy Hospital
🇪🇬Cairo, Egypt